DIH Holdings US, Inc. Class A Common Stock (DHAI) - Net Assets
Based on the latest financial reports, DIH Holdings US, Inc. Class A Common Stock (DHAI) has net assets worth $-37.13 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($26.75 Million) and total liabilities ($63.89 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of DIH Holdings US, Inc. Class A Common Sto to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-37.13 Million |
| % of Total Assets | -138.81% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
DIH Holdings US, Inc. Class A Common Stock - Net Assets Trend (2020–2025)
This chart illustrates how DIH Holdings US, Inc. Class A Common Stock's net assets have evolved over time, based on quarterly financial data. Also explore DIH Holdings US, Inc. Class A Common Sto total assets for the complete picture of this company's asset base.
Annual Net Assets for DIH Holdings US, Inc. Class A Common Stock (2020–2025)
The table below shows the annual net assets of DIH Holdings US, Inc. Class A Common Stock from 2020 to 2025. For live valuation and market cap data, see DIH Holdings US, Inc. Class A Common Sto market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-37.13 Million | -14.10% |
| 2024-12-31 | $-32.55 Million | 0.00% |
| 2023-12-31 | $-32.55 Million | 0.00% |
| 2022-12-31 | $-32.55 Million | -23.18% |
| 2021-12-31 | $-26.42 Million | -63.25% |
| 2020-12-31 | $-16.18 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to DIH Holdings US, Inc. Class A Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4388800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Comprehensive Income | $1.48 Million | % |
| Other Components | $5.27 Million | % |
| Total Equity | $-37.13 Million | 100.00% |
DIH Holdings US, Inc. Class A Common Stock Competitors by Market Cap
The table below lists competitors of DIH Holdings US, Inc. Class A Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Braveheart Investment Group
LSE:BRH
|
$21.01K |
|
MediaZest plc
LSE:MDZ
|
$21.16K |
|
Karelian Diamond Resources PLC
LSE:KDR
|
$21.51K |
|
MONTEGO RESOURCES INC.
F:4MO
|
$21.52K |
|
Carisma Therapeutics Inc.
NASDAQ:CARM
|
$20.92K |
|
Bluebird Merchant Ventures Ltd
LSE:BMV
|
$20.83K |
|
Clontarf Energy Plc
LSE:CLON
|
$20.44K |
|
Office Properties Income Trust
NASDAQ:OPINL
|
$20.06K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DIH Holdings US, Inc. Class A Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -32,546,000 to -37,135,000, a change of -4,589,000.
- Net loss of 8,676,000 reduced equity.
- Other comprehensive income increased equity by 1,429,000.
- Other factors increased equity by 2,658,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-8.68 Million | -23.36% |
| Other Comprehensive Income | $1.43 Million | +3.85% |
| Other Changes | $2.66 Million | +7.16% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares DIH Holdings US, Inc. Class A Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $-12.23 | $0.03 | x |
| 2021-12-31 | $-19.97 | $0.03 | x |
| 2022-12-31 | $-32.55 | $0.03 | x |
| 2023-12-31 | $-1.23 | $0.03 | x |
| 2024-12-31 | $-30.84 | $0.03 | x |
| 2025-12-31 | $-25.96 | $0.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DIH Holdings US, Inc. Class A Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.80%
- • Asset Turnover: 2.35x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | -22.84% | 1.23x | 0.00x | $-9.23 Million |
| 2021 | 0.00% | -24.58% | 1.44x | 0.00x | $-9.41 Million |
| 2022 | 0.00% | -4.29% | 1.54x | 0.00x | $893.60K |
| 2023 | 0.00% | -13.10% | 1.80x | 0.00x | $-5.19 Million |
| 2024 | 0.00% | -13.10% | 1.80x | 0.00x | $-5.19 Million |
| 2025 | 0.00% | -13.80% | 2.35x | 0.00x | $-4.96 Million |
Industry Comparison
This section compares DIH Holdings US, Inc. Class A Common Stock's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,432,799,891
- Average return on equity (ROE) among peers: -74.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DIH Holdings US, Inc. Class A Common Stock (DHAI) | $-37.13 Million | 0.00% | N/A | $20.93K |
| Abbott Laboratories (ABT) | $24.16 Billion | 9.46% | 0.81x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-13.54K | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $2.15 Million | -112.84% | 0.45x | $16.04 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.60 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $89.39 Million | 8.74% | 0.25x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $21.15 Million | 2.82% | 0.30x | $125.55 Million |
About DIH Holdings US, Inc. Class A Common Stock
DIH Holding US, Inc. provides advanced robotic devices used in physical rehabilitation in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; and Armeo… Read more